The BNF for Children aims to provide prescribers, pharmacists, and other health professionals with up-to-date information on the use of medicines in pediatrics.
A joint publication of the British Medical Association, the Royal Pharmaceutical Society, the Royal College of Pediatrics and Child Health, and the neonatal and pediatric pharmacist group, BNF for Children (‘BNFC’), is published under the auspices of the Pediatric Formulary Committee. Representatives from these agencies include the Department for Health in England, and the Medicines and Healthcare Products Regulatory Agency.
Many areas of children’s exercise have experienced insufficient information about effective medicine. BNFC this sign while providing practical information on drug use in children of all ages from birth to adolescence. Does not pay attention to academic distance. The information contained in the BNFC has been verified against emerging evidence, best practice guidelines, and, most importantly, the advice of a network of medical experts.
The BNFC, which produces information from manufacturers’ literature where appropriate, also includes a lot of advice that goes beyond marketing licenses. This is important because licensed indicators often do not meet children’s medical needs. In some cases, products used in children need to be specially manufactured or imported. Careful consideration has been given to establishing the medical requirement of unlicensed intervention in relation to their safety evidence and experience. In this process, local children’s formulas, medical literature and national information resources have been invaluable.